<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>心血管高解释</title><link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;ff=20250219071916&amp;fc = 20230708114047<description>心血管高额外版：PubMed的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;ff=20250219071916&amp;fc=20230708114047" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS提要（2.18.0.post9+E462414）</generator><language> en</language><lastbuilddate>星期三，2025年2月19日12:19:18 +0000</lastbuilddate><pubDate> Wed, 19 Feb 2025 06:00:00 -0500</pubDate><ttl> 120</ttl><item><title>美国生物医学研究未来的原则，并优化国立卫生研究院：美国心脏协会的总统咨询</title><link/>https://pubmed.ncbi.nlm.nih.gov/39968665/？ 708114047＆ff = 20250219071916＆v = 2.18.0.post9+e462414<description>在过去的7年中，科学和医学的开创性成就有助于减少心血管疾病和中风死亡率。不幸的是，重要的经济回报，包括支持>; 40万个工作岗位和大约930亿美元的经济活动。公共资金有... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>循环</b>。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">在过去的7年中，科学和医学的开创性成就有助于减少心血管疾病和中风死亡率。不幸的是，重要的经济回报，包括支持>; 40万个工作岗位和大约930亿美元的经济活动。公共资金并没有与疾病的燃烧或通货膨胀率保持一致。代表患者，临床医生和科学家以及作为研究基金，我们提供以下原则，以优化美国生物医学研究企业的未来尤其是美国国家卫生研究院，应将创新和有影响力的研究优先考虑；并确保对未来的强大和可靠的投资。资助和实施基于生物医学和人群的研究计划，这些计划产生重要的经济回报，这些机构对于支持当今和未来的健康挑战至关重要，以推动基础科学，改善患者的健康解决上游和预防策略，并提高我们的公共卫生和医疗保健投资的价值。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39968665/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39968665</a> <a href=https://doi.org/10.1161/CIR.0000000000001319>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39968665</guid><pubDate> Wed, 19 Feb 2025 06:00:00 -0500</pubDate><dc:creator>约瑟夫·C·吴（Joseph C Wu）</dc:creator><dc:creator> Donna K Arnett</dc:creator><dc:creator> Ivor J Benjamin</dc:creator><dc:creator>标记一个折痕</dc:creator><dc:creator>罗伯特·哈灵顿</dc:creator><dc:creator>约瑟夫·阿山</dc:creator><dc:creator>P迈克尔·何</dc:creator><dc:creator>史蒂文·H·霍瑟（Steven R Houser）</dc:creator><dc:creator>斯蒂芬妮·斯卡莫（Stephanie Scarmo）</dc:creator><dc:creator> Svati H Shah</dc:creator><dc:creator> Gordon F Tomaselli</dc:creator><dc:creator>美国心脏协会</dc:creator><dc:date>2025-02-19</dc:date><dc:source>循环</dc:source><dc:title>美国生物医学研究未来的原则，并优化国立卫生研究院：美国心脏协会的总统咨询</dc:title><dc:identifier>PMID：39968665</dc:identifier><dc:identifier> doi：10.1161/cir.0000000001319</dc:identifier></item><item><title> 4A型心肌违规和腹膜围攻性心肌损伤的预后相关性</title><link/>https://pubmed.ncbi.nlm.nih.gov/39968630/？ 08114047＆ff = 20250219071916＆v = 2.18.0.post9+e462414<description>结论：腹部缺血性事件经常在具有预后意义的NSTEMI患者中，PCIΔCtni>; 40％，与绝对的后术相结合，是99％的上级参考限制的最佳阈值。诊断预后相关的PMI。 Nstemi。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>循环</b>。2025年2月19日。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：在经皮冠状动脉干预后（PCI）的非ST段 - 段MI（NSTEMI）患者中，可能发生有或没有4A型心肌梗死（MI）的围骨心肌损伤（PMI）。根据当前的定义，这些事件在患有PCI的患者中。还建议分层。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：根据心肌违规的第四个普遍定义，将稳定或稳定的PCI CTNI水平的PCI纳入PCI。 4A MI，（2）无4A型MI的PMI，或（3）无PMI。在使用PCI定义PMI后48小时内的第99个百分位数上限限制的过程后值≥5倍。 ，包括全因死亡率，非致命性重新性，紧急血运重建，非致命性缺血性中风和心力衰竭的住院治疗。在2022年5月至2023年4月之间参加。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：在1412例NSTEMI患者中，基线时具有稳定或CTNI水平下降的PCI，240（17％）经历了4A型MI型PMI，288（20.4％）经历了没有4A型MI型的PMI，而没有884（62.6％）的PMI经历PMI。主要不良心血管事件。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：腹部缺血性事件经常在具有预后意义的NSTEMI患者中，PCIΔCtni>; 40％，与绝对的后术相结合，是99％的上级参考限制的最佳阈值。诊断预后相关的PMI。 Nstemi。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39968630/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39968630</a> <a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070729>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39968630</guid><pubDate> Wed, 19 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Matteo Armillotta</dc:creator><dc:creator> Luca Bergamaschi</dc:creator><dc:creator> Pasquale Paolisso</dc:creator><dc:creator> Marta Belmonte</dc:creator><dc:creator>弗朗切斯科·安吉利（Francesco Angeli）</dc:creator><dc:creator> Angelo Sansonetti</dc:creator><dc:creator> Andrea Stefanizzi</dc:creator><dc:creator>戴维德·贝尔托利尼（Davide Bertolini）</dc:creator><dc:creator> Francesca Bodega</dc:creator><dc:creator>萨拉疗程</dc:creator><dc:creator>丽莎广州</dc:creator><dc:creator>达米亚诺·费德尔（Damiano Fedele）</dc:creator><dc:creator>妮可·苏玛（Nicole Suma）</dc:creator><dc:creator> Andrea Impellizzeri</dc:creator><dc:creator> Francesco Pio Tattilo</dc:creator><dc:creator> Daniele Cavallo</dc:creator><dc:creator> Ornella di iuorio</dc:creator><dc:creator> Khrystyna Ryabenko</dc:creator><dc:creator> Andrea Rinaldi</dc:creator><dc:creator> Gabriele Ghetti</dc:creator><dc:creator> Francesco Sai</dc:creator><dc:creator> Cinzia Marrozzini</dc:creator><dc:creator>吉安尼·卡塞拉（Gianni Casela）</dc:creator><dc:creator> Paola Rucci</dc:creator><dc:creator> Albertofoà</dc:creator><dc:creator> Carmine Pizzi</dc:creator><dc:date> 2025-02-19</dc:date><dc:source>循环</dc:source><dc:title>4A型心肌违规和腹膜围攻性心肌损伤的预后相关性</dc:title><dc:identifier>PMID：39968630</dc:identifier><dc:identifier> doi：10.1161/CirculationAha.124.070729</dc:identifier></item><item><title>可穿戴血压传感器用于心血管监测和机器学习算法，用于血压估计</title><link/>https://pubmed.ncbi.nlm.nih.gov/39966649/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250219071916&amp;v=2.18.0.post9+e462414<description>随着材料科学和医疗技术的进步，可穿戴的传感器已成为早期诊断和连续监测多种心血管疾病的关键工具，包括心律不齐，高血压和冠状动脉疾病。和电生理方法，以测量重要的生物信号，包括脉搏率，血压和心脏变化节奏。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Nat Rev Cardiol。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">随着材料科学和医疗技术的进步，可穿戴的传感器已成为早期诊断和连续监测多种心血管疾病的关键工具，包括心律不齐，高血压和冠状动脉疾病。和电生理方法，以测量重要的生物信号，包括脉搏率，血压和心脏变化节奏。在这篇评论中，我们提供了可穿戴的心血管传感器的当前状态，尤其是探索血压的人。无袖口的可穿戴式血压传感器的进步。从技术和临床角度来看，医疗领域的无袖戴可穿戴压力传感器。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39966649/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">3996649</a> <a href=https://doi.org/10.1038/s41569-025-01127-0>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39966649</guid><pubDate> Tue, 18 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Seongwook Min</dc:creator><dc:creator> Jaehun an</dc:creator><dc:creator> Jae Hee Lee</dc:creator><dc:creator> Ji Hoon Kim</dc:creator><dc:creator>丹尼尔·J·乔</dc:creator><dc:creator>Soo Hwan Eom</dc:creator><dc:creator> Chang D Yoo</dc:creator><dc:creator> hyo-suk ahn</dc:creator><dc:creator> Jin-Young Hwang</dc:creator><dc:creator> Sheng Xu</dc:creator><dc:creator>约翰·罗杰斯</dc:creator><dc:creator>Keon Jae Lee</dc:creator><dc:date> 2025-02-18</dc:date><dc:source>自然评论</dc:source><dc:title>可穿戴血压传感器用于心血管监测和机器学习算法，用于血压估计</dc:title><dc:identifier>PMID：39966649</dc:identifier><dc:identifier> doi：10.1038/s41569-025-01127-0</dc:identifier></item><item><title>低氧基质，一种小分子的低氧疗法，增加了氧血红蛋白亲和力</title><link/>https://pubmed.ncbi.nlm.nih.gov/39965572/？ 708114047＆ff = 20250219071916＆v = 2.18.0.post9+e462414<description>我们以前已经证明，在线粒体利利综合征的主要动物模型中，慢性遗传的缺氧是NDUFS4敲除（KO）小鼠的最佳动物模型。基于基础的疗法阻碍了我们的发现向诊所的快速翻译。这增加了结合... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Cell</b> 。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">我们以前已经证明，在线粒体利利综合征的主要动物模型中，慢性遗传的缺氧是NDUFS4敲除（KO）小鼠的最佳动物模型。基于基础的疗法阻碍了我们的发现向诊所的快速翻译。这增加了血红蛋白对氧气的结合亲和力，从而减少了氧气的氧气剂量，使氧气降低到组织中，导致小鼠的全身性缺氧呼吸normagion（21％O <sub>2</sub> ）。 NDUFS4 KO小鼠并拯救了疾病的其他方面，包括行为，体重，神经病理学和体温可以在很晚的阶段逆转疾病，从而作为缺氧治疗的一种临床疗法形式。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39965572/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39965572</a> <a href=https://doi.org/10.1016/j.cell.2025.01.029>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39965572</guid><pubDate> Tue, 18 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Skyler Y Blume</dc:creator><dc:creator> Ankur Garg</dc:creator><dc:creator> YolandaMartí-Mateos</dc:creator><dc:creator> Ayush D Midha</dc:creator><dc:creator>布兰登TL咀嚼</dc:creator><dc:creator>Baiwei Lin</dc:creator><dc:creator>塞西尔·尤</dc:creator><dc:creator>瑞安·迪克（Ryan Dick）</dc:creator><dc:creator>帕特里克·李</dc:creator><dc:creator>EVA网站</dc:creator><dc:creator>Richa Sarwaikar</dc:creator><dc:creator>埃里克·格林（Eric Green）</dc:creator><dc:creator>维斯·拉曼南（Vyas Ramanan）</dc:creator><dc:creator> Gijsbert Grotenbreg</dc:creator><dc:creator> Maarten Hoek</dc:creator><dc:creator>克里斯托弗·辛兹（Christopher Sinz）</dc:creator><dc:creator> Isha H Jain</dc:creator><dc:date> 2025-02-18</dc:date><dc:source>细胞</dc:source><dc:title>低氧基质，一种小分子的低氧疗法，增加了氧血红蛋白亲和力</dc:title><dc:identifier>PMID：39965572</dc:identifier><dc:identifier> doi：10.1016/j.cell.2025.01.029</dc:identifier></item><item><title>心肌功能的ESC工作组</title><link/>https://pubmed.ncbi.nlm.nih.gov/39964361/？ 708114047＆ff = 20250219071916＆v = 2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2025年2月18日：Ehae016。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39964361/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39964361</a> <a href=https://doi.org/10.1093/eurheartj/ehae016>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39964361</guid><pubDate> Tue, 18 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Mahmoud Abdellatif</dc:creator><dc:creator> Wolfgang linke</dc:creator><dc:creator> Dana K Dawson</dc:creator><dc:creator> ESC的心肌功能工作组</dc:creator><dc:date>2025-02-18</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>心肌功能的ESC工作组</dc:title><dc:identifier>PMID：39964361</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehae016</dc:identifier></item><item><title>亚太地区心血管疾病的风险预测：是否分开亚型，这是一个新问题</title><link/>https://pubmed.ncbi.nlm.nih.gov/39964356/？ 708114047＆ff = 20250219071916＆v = 2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2025年2月18日：Ehae854：10.1093/Eurheartj/ehae854。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39964356/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39964356</a> <a href=https://doi.org/10.1093/eurheartj/ehae854>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39964356</guid><pubDate> Tue, 18 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Songchun Yang</dc:creator><dc:creator> Jun LV</dc:creator><dc:date> 2025-02-18</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>亚太地区心血管疾病的风险预测：是否分开亚型，这是一个新问题</dc:title><dc:identifier>PMID：39964356</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehae854</dc:identifier></item><item><title> Score2亚太：一种预防心血管疾病的综合方法</title><link/>https://pubmed.ncbi.nlm.nih.gov/39964347/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250219071916&amp;v=2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2025年2月18日：Ehae855：10.1093/EurheartJ/Ehae855。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39964347/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39964347</a> <a href=https://doi.org/10.1093/eurheartj/ehae855>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39964347</guid><pubDate> Tue, 18 Feb 2025 06:00:00 -0500</pubDate><dc:creator>史蒂文·HJ哈格曼</dc:creator><dc:creator>索菲安·乔哈尔（Sofian Johar）</dc:creator><dc:creator>弗兰克·LJ Visseren</dc:creator><dc:creator> Score2亚太写作小组</dc:creator><dc:date>2025-02-18</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>Score2亚太：一种预防心血管疾病的综合方法</dc:title><dc:identifier>PMID：39964347</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehae855</dc:identifier></item><item><title>手术主动脉瓣置换和长期结局后，与性别相关的假体不匹配差异</title><link/>https://pubmed.ncbi.nlm.nih.gov/39964038/？ 708114047＆ff = 20250219071916＆v = 2.18.0.post9+e462414<description>结论：这项大型区域研究中出现的与结果相关的性别特异性EOAI阈值表明，男性的PPM定义可能比女性更高。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2025年2月18日：EHAF076。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景和目的：假体不匹配（PPM）与主动脉瓣替代后的沮丧预后有关（AVR）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在2000年至2021年之间，在魁北克省de Cardiologie et de de de de de de de de de de de de de de de the decortium-3（varc-3），有7319名患者在Quardiologie et de Qurebec进行了手术AVR。 -3）标准。建立了死亡率，并由魁北克国家数据库调整了CV死亡率。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：根据VARC-的说法，任何程度的PPM都比男性（31.9％vs. 19.7％，P &lt;.0001）更为普遍，严重PPM的罕见事件（2.4％vs. 0.6％，P &lt;.0001） 3定义，在12。6年的中位随访中，有3231个（44.1％）全因死亡，cv造成了1238年（16.9％）。 （危险比1.30，95％CI 1.20-1.40; p &lt;.0001）和CV死亡率（危险比1.39，95％CI 1.23-1.57; p &lt;.0001）在整个人群中都没有性别之间的相互作用（p≥.7444） ）。性别，ppm与两性的结果独立相关（p≤.04）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：这项大型区域研究中出现的与结果相关的性别特异性EOAI阈值表明，男性的PPM定义可能比女性更高。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39964038/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39964038</a> <a href=https://doi.org/10.1093/eurheartj/ehaf076>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39964038</guid><pubDate> Tue, 18 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Paolo Springhetti</dc:creator><dc:creator>凯蒂亚·阿卜杜恩（Kathia Abdoun）</dc:creator><dc:creator> ÉricDumont</dc:creator><dc:creator> FrançoisDagenais</dc:creator><dc:creator> Dimitri Kalavrouziotis</dc:creator><dc:creator>暹罗穆罕默迪</dc:creator><dc:creator>Philippe Pibarot</dc:creator><dc:creator>玛丽·安妮克·克拉维（Marie-Annick Clavel）</dc:creator><dc:date> 2025-02-18</dc:date><dc:source>欧洲心脏期刊</dc:source><dc:title>手术主动脉瓣置换和长期结局后，与性别相关的假体不匹配差异</dc:title><dc:identifier>PMID：39964038</dc:identifier><dc:identifier> doi：10.1093/eurheartj/ehaf076</dc:identifier></item><item><title> &lt;em>;税务1bp3 &lt;/em>;导致TRPV4介导的常染色体隐性心律失常性心肌病</title><link/>https://pubmed.ncbi.nlm.nih.gov/39963794/？ 708114047＆ff = 20250219071916＆v = 2.18.0.post9+e462414<description>结论：我们包括税收1BP3与稀有的常染色体隐性ACM有关，通过TRPV4介导的CA^（2+）泄漏，TRPV4当前的抑制作用有可能成为ACM的新治疗靶标。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> CIRC RES。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：心律不齐的心肌病（ACM）是儿童，年轻人和运动员突然心脏死亡的主要原因之一，其特征是纤维脂肪替代肌膜，主要是右心室患者。有一个已知的遗传原因，但在其余的情况下，病因尚不清楚。疗法和ACM儿童具有高度的发病率和死亡率。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：将3个家族成员的诱导多能干细胞（IPSC）分化为心肌细胞（CMS） - 进行了特异性的，可诱导的基因敲除小鼠（税务1bp3 <sup>- / -</sup> ），并进行了心脏内生理研究以观察心律不齐起搏后的诱导性。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：我们确定了一个受ACM cosegregniant coselelic变体影响的属性，该基因税收<i>1BP3</i>编码了蛋白质税收1BP3（税务1结合蛋白3）。 （瞬态接收器势型4型）表达，诱导型TRPV4电流与细胞内耗尽有关肌质网Ca <sup>2+</sup>存储和RYR2增加（Ryanodine受体2）介导的储存Ca <sup>2+</sup>泄漏并延迟了pepolarisation，<sup>这</sup>是Ca <sup>2+</sup>介导的心律失常的已知机制。与野生型小鼠相比，易于心律不齐<sup>。</sup>通过<sup>小</sup>分子TRPV4抑制作用。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：我们包括<i>税收1B3</i>与稀有的常染色体隐性ACM通过TRPV4介导的Ca <sup>2+</sup>从RYR2进一步泄漏。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39963794/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39963794</a> <a href=https://doi.org/10.1161/CIRCRESAHA.124.325180>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39963794</guid><pubDate> Tue, 18 Feb 2025 06:00:00 -0500</pubDate><dc:creator>罗宾·佩雷利（Robin M Perelli）</dc:creator><dc:creator> Enya R Dewars</dc:creator><dc:creator>海蒂·科普（Heidi Cope）</dc:creator><dc:creator>亚历山大·贝拉（Alexander S Behura）</dc:creator><dc:creator> Anna Q Ponek</dc:creator><dc:creator>安吉丽娜·萨拉（Angelina M Sala）</dc:creator><dc:creator> Zhushan Zhang</dc:creator><dc:creator> padmapriya muralidharan</dc:creator><dc:creator>玛丽·莫亚·孟德斯</dc:creator><dc:creator>艾米·伯克曼（Amy Berkman）</dc:creator><dc:creator>加布里埃尔·G摩纳哥</dc:creator><dc:creator>Molly C Sullivan</dc:creator><dc:creator>乔丹·埃塞基安（Jordan Ezekian）</dc:creator><dc:creator> Qixin Yang</dc:creator><dc:creator> Bo Sun</dc:creator><dc:creator> Leonie M Kurzlechner</dc:creator><dc:creator> Tulsi Asokan</dc:creator><dc:creator>安德鲁·布雷格里奥（Andrew M Breglio）</dc:creator><dc:creator> M Jay Campbell</dc:creator><dc:creator> Zebulon Z Spector</dc:creator><dc:creator>凯瑟琳·韦德</dc:creator><dc:creator>未诊断的疾病网络</dc:creator><dc:creator>Paul C Tang</dc:creator><dc:creator>辛西娅·詹姆斯</dc:creator><dc:creator>休·卡尔金斯</dc:creator><dc:creator>Vandana Shashi</dc:creator><dc:creator>安德鲁P Landstrom</dc:creator><dc:date> 2025-02-18</dc:date><dc:source>循环研究</dc:source><dc:title>&lt;em>;税务1bp3 &lt;/em>;导致TRPV4介导的常染色体隐性心律失常性心肌病</dc:title><dc:identifier>PMID：39963794</dc:identifier><dc:identifier> doi：10.1161/circresaha.124.325180</dc:identifier></item><item><title>小腿肌肉在外周动脉疾病和慢性肾脏疾病中的多态分析</title><link/>https://pubmed.ncbi.nlm.nih.gov/39963788/？ 708114047＆ff = 20250219071916＆v = 2.18.0.post9+e462414<description>结论：CKD在PAD中显着加剧缺血性肌肉病理学，这是通过肌肉强度降低，线粒体功能降低和转录组谱的变化所证明的CKD患者。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> CIRC RES。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：慢性肾脏疾病（CKD）已成为加速动脉粥样硬化，降低肌肉功能并增加截肢或死亡的重要危险因素，但外围动脉疾病患者（PAD）是这种恶化的病理生物学。不确定的工作表明，尿毒症毒素与pAD中的肢体截肢有关肢体肌肉和脉管系统。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：一项横断面研究招募了4组参与者：无PAD或CKD的对照（n = 28），仅患有PAD的患者（n = 46），仅CKD患者（n = 31）（n = 31），以及PAD和PAD和PAD和CKD（n = 18）。 RNA测序和评估线粒体功能。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：与对照组相比，患有PAD和CKD的患者与对照组相比，小腿肌肉强度和较小的肌肉纤维区域相比，与对照组相比，线粒体功能在CKD患者中受到了损害没有CKD的患者。观察到尿毒症毒素（例如，kynurenine和Indoxyl硫酸盐）与肌肉强度和线粒体功能之间的相关性。肌肉纤维的线粒体缺乏以及纤维辅助祖细胞在独特的重塑中PAD和CKD的患者，成脂细胞群的增加。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：CKD在PAD中显着加剧缺血性肌肉病理学，这是通过肌肉强度降低，线粒体功能降低和转录组谱的变化所证明的CKD患者。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39963788/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39963788</a> <a href=https://doi.org/10.1161/CIRCRESAHA.124.325642>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39963788</guid><pubDate> Tue, 18 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Kyoungrae Kim</dc:creator><dc:creator>追踪thome</dc:creator><dc:creator>卡罗琳通行证</dc:creator><dc:creator>劳伦·斯通</dc:creator><dc:creator>尼古拉斯·维格曼（Nicholas Vugman）</dc:creator><dc:creator>维多利亚·帕尔茨基尔（Victoria Palzkill）</dc:creator><dc:creator>清楚杨</dc:creator><dc:creator>Kerri A O&#39;Malley</dc:creator><dc:creator>埃里克·M·安德森（Erik M Anderson）</dc:creator><dc:creator> Brian Fazzone</dc:creator><dc:creator>冯尤</dc:creator><dc:creator>斯科特·贝克利（Bercelli）</dc:creator><dc:creator> Salvatore t scali</dc:creator><dc:creator> Terence E Ryan</dc:creator><dc:date> 2025-02-18</dc:date><dc:source>循环研究</dc:source><dc:title>小腿肌肉在外周动脉疾病和慢性肾脏疾病中的多态分析</dc:title><dc:identifier>PMID：39963788</dc:identifier><dc:identifier> doi：10.1161/circresaha.124.325642</dc:identifier></item><item><title>性染色体和性激素：解剖区分女性和男性心的力量</title><link/>https://pubmed.ncbi.nlm.nih.gov/39960989/？ 708114047＆ff = 20250219071916＆v = 2.18.0.post9+e462414<description>心脏是一种高度偏见的器官，性别塑造了心脏健康和性疾病的无数方面。雌激素的绝缘作用被严格审问和审查，而性别染色体，睾丸激素和孕酮的影响仍然存在争议或不确定。我们合成... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>循环</b>。2025年2月18日； 151（7）：474-489。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">心脏是一种高度偏见的器官，性别塑造了心脏健康和性疾病的无数方面。雌激素的绝缘作用被严格审问和审查，而性别染色体，睾丸激素和孕酮的影响仍然存在争议或不确定。我们综合了越来越多的证据表明，性别染色体和性恐怖基本上是依赖于上下文的方式，其功能和功能障碍。劝阻女性受试者纳入基础科学中，例如女性发情循环的影响以及生殖效率对数据可靠性和此外，我们权衡了几种通用的策略，以拦截和挽救性别的保护，我们警告动物食物和细胞培养物中的常见化合物，以干扰雌激素信号。源自性交性的心血管研究，比较心脏性偏差的可能原因，阐明心脏中的性别染色体或依赖马的性过程，描述了常见的失误雌性和雄性细胞和动物的工作，以及女性心脏的照明方面，尚未探索或仍然不确定。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39960989/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39960989</a> <a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069493>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39960989</guid><pubDate> Mon, 17 Feb 2025 06:00:00 -0500</pubDate><dc:creator>安妮·布朗</dc:creator><dc:creator>Aikaterini Kontrogianni-Konstantopoulos</dc:creator><dc:date> 2025-02-17</dc:date><dc:source>循环</dc:source><dc:title>性染色体和性激素：解剖区分女性和男性心的力量</dc:title><dc:identifier>PMID：39960989</dc:identifier><dc:identifier> doi：10.1161/CirculationAha.124.069493</dc:identifier></item><item><title>培养领导力和推动成长的框架</title><link/>https://pubmed.ncbi.nlm.nih.gov/39960988/？ 708114047＆ff = 20250219071916＆v = 2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>循环</b>。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39960988/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39960988</a> <a href=https://doi.org/10.1161/CIRCULATIONAHA.124.073352>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39960988</guid><pubDate> Mon, 17 Feb 2025 06:00:00 -0500</pubDate><dc:creator>弗朗西斯卡（Francesca）空缺</dc:creator><dc:creator>Zehra Yildirim</dc:creator><dc:creator>约瑟夫·C·吴（Joseph C Wu）</dc:creator><dc:date> 2025-02-17</dc:date><dc:source>循环</dc:source><dc:title>培养领导力和推动成长的框架</dc:title><dc:identifier>PMID：39960988</dc:identifier><dc:identifier> doi：10.1161/CirculationAha.124.073352</dc:identifier></item><item><title>解决土著妇女的心血管健康不平等：澳大利亚的见解和全球视角</title><link/>https://pubmed.ncbi.nlm.nih.gov/39960987/？ 708114047＆ff = 20250219071916＆v = 2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>循环</b>。2025年2月18日； 151（7）：427-429。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39960987/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39960987</a> <a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072828>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39960987</guid><pubDate> Mon, 17 Feb 2025 06:00:00 -0500</pubDate><dc:creator>杰西·纳利普迪</dc:creator><dc:creator>贝森·凯利</dc:creator><dc:creator>Ashutosh Hardikar</dc:creator><dc:date> 2025-02-17</dc:date><dc:source>循环</dc:source><dc:title>解决土著妇女的心血管健康不平等：澳大利亚的见解和全球视角</dc:title><dc:identifier>PMID：39960987</dc:identifier><dc:identifier> doi：10.1161/CirculationAha.124.072828</dc:identifier></item><item><title>高血压或糖尿病复杂的糖尿病和血脂异常的人口级筛查</title><link/>https://pubmed.ncbi.nlm.nih.gov/39960986/？ 708114047＆ff = 20250219071916＆v = 2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>循环</b>。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39960986/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39960986</a> <a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072067>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39960986</guid><pubDate> Mon, 17 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Amy YX Yu</dc:creator><dc:creator>纳塔莉·奥格尔（Nathalie Auger）</dc:creator><dc:creator> Longdi Fu</dc:creator><dc:creator>安娜楚</dc:creator><dc:creator>Moira K Kapral</dc:creator><dc:creator>乔迪·爱德华兹（Jodi D Edwards）</dc:creator><dc:creator> Sonia R Dancey</dc:creator><dc:creator>彼得·奥斯汀</dc:creator><dc:creator>manav v vyas</dc:creator><dc:creator> Kara A Nerenberg</dc:creator><dc:date> 2025-02-17</dc:date><dc:source>循环</dc:source><dc:title>高血压或糖尿病复杂的糖尿病和血脂异常的人口级筛查</dc:title><dc:identifier>PMID：39960986</dc:identifier><dc:identifier> doi：10.1161/CirculationAha.124.072067</dc:identifier></item><item><title>结构性心脏病，介入的超声心动图和被遗忘的阀门的有远见者：与Rebecca T. Hahn的对话</title><link/>https://pubmed.ncbi.nlm.nih.gov/39960985/？ 708114047＆ff = 20250219071916＆v = 2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>循环</b>。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39960985/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39960985</a> <a href=https://doi.org/10.1161/CIRCULATIONAHA.125.072189>|</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39960985</guid><pubDate> Mon, 17 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Maryjane Farr</dc:creator><dc:date> 2025-02-17</dc:date><dc:source>循环</dc:source><dc:title>结构性心脏病，介入的超声心动图和被遗忘的阀门的有远见者：与Rebecca T. Hahn的对话</dc:title><dc:identifier>PMID：39960985</dc:identifier><dc:identifier> doi：10.1161/CirculationAha.125.072189</dc:identifier></item><item><title>第九届年度妇女发红</title><link/>https://pubmed.ncbi.nlm.nih.gov/39960984/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250219071916&amp;v=2.18.0.post9+e462414<description>没有抽象</description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>循环</b>。</p><p><b>没有抽象</b></p><p style="color: lightgray">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39960984/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39960984</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.125.073852>10.1161/CIRCULATIONAHA.125.073852</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39960984</guid><pubDate> Mon, 17 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Sana M Al-Khatib</dc:creator><dc:creator> Joseph A Hill</dc:creator><dc:creator> Mercedes Carnethon</dc:creator><dc:date> 2025-02-17</dc:date><dc:source>循环</dc:source><dc:title>Ninth Annual Go Red for Women Issue</dc:title><dc:identifier> pmid:39960984</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.125.073852</dc:identifier></item><item><title> Hypertension in Pregnancy and Postpartum: Current Standards and Opportunities to Improve Care</title><link/> https://pubmed.ncbi.nlm.nih.gov/39960983/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250219071916&amp;v=2.18.0.post9+e462414<description> Hypertension in pregnancy contributes substantially to maternal morbidity and mortality, persistent hypertension, and rehospitalization. Hypertensive disorders of pregnancy are also associated with a heightened risk of cardiovascular disease, and timely recognition and modification of associated risk factors is crucial in optimizing long-term maternal health. During pregnancy, there are expected physiologic alterations in blood pressure (BP); however, pathophysiologic alterations may also occur,... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2025 Feb 18;151(7):490-507. doi: 10.1161/CIRCULATIONAHA.124.073302. Epub 2025 Feb 17.</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Hypertension in pregnancy contributes substantially to maternal morbidity and mortality, persistent hypertension, and rehospitalization. Hypertensive disorders of pregnancy are also associated with a heightened risk of cardiovascular disease, and timely recognition and modification of associated risk factors is crucial in optimizing long-term maternal health. During pregnancy, there are expected physiologic alterations in blood pressure (BP); however, pathophysiologic alterations may also occur, leading to preeclampsia and gestational hypertension. The diagnosis and effective management of hypertension during pregnancy is essential to mitigate maternal risks, such as acute kidney injury, stroke, and heart failure, while balancing potential fetal risks, such as growth restriction and preterm birth due to altered uteroplacental perfusion. In the postpartum period, innovative and multidisciplinary care solutions that include postpartum maternal health clinics can help optimize short- and long-term care through enhanced BP management, screening of cardiovascular risk factors, and discussion of lifestyle modifications for cardiovascular disease prevention. As an adjunct to or distinct from postpartum clinics, home BP monitoring programs have been shown to improve BP ascertainment across diverse populations and to lower BP in the months after delivery. Because of concerns about pregnant patients being a vulnerable population for research, there is little evidence from trials examining the diagnosis and treatment of hypertension in pregnant and postpartum individuals. As a result, national and international guidelines differ in their recommendations, and more studies are needed to bolster future guidelines and establish best practices to achieve optimal cardiovascular health during and after pregnancy. Future research should focus on refining treatment thresholds and optimal BP range peripartum and postpartum and evaluating interventions to improve postpartum and long-term maternal cardiovascular outcomes that would advance evidence-based care and improve outcomes worldwide for people with hypertensive disorders of pregnancy.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39960983/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39960983</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.124.073302>10.1161/CIRCULATIONAHA.124.073302</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39960983</guid><pubDate> Mon, 17 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Malamo Countouris</dc:creator><dc:creator> Zainab Mahmoud</dc:creator><dc:creator> Jordana B Cohen</dc:creator><dc:creator> Daniela Crousillat</dc:creator><dc:creator> Afshan B Hameed</dc:creator><dc:creator> Colleen M Harrington</dc:creator><dc:creator> Alisse Hauspurg</dc:creator><dc:creator> Michael C Honigberg</dc:creator><dc:creator> Jennifer Lewey</dc:creator><dc:creator> Kathryn Lindley</dc:creator><dc:creator> Megan M McLaughlin</dc:creator><dc:creator> Neha Sachdev</dc:creator><dc:creator> Amy Sarma</dc:creator><dc:creator> Kayle Shapero</dc:creator><dc:creator> Rachel Sinkey</dc:creator><dc:creator> Alan Tita</dc:creator><dc:creator> Kristen E Wong</dc:creator><dc:creator> Eugene Yang</dc:creator><dc:creator> Leslie Cho</dc:creator><dc:creator> Natalie A Bello</dc:creator><dc:date> 2025-02-17</dc:date><dc:source>循环</dc:source><dc:title>Hypertension in Pregnancy and Postpartum: Current Standards and Opportunities to Improve Care</dc:title><dc:identifier> pmid:39960983</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.124.073302</dc:identifier></item><item><title> Missing (Black) Women</title><link/> https://pubmed.ncbi.nlm.nih.gov/39960982/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250219071916&amp;v=2.18.0.post9+e462414<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2025 Feb 18;151(7):433-435. doi: 10.1161/CIRCULATIONAHA.124.072699. Epub 2025 Feb 17.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39960982/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39960982</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072699>10.1161/CIRCULATIONAHA.124.072699</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39960982</guid><pubDate> Mon, 17 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Tené T Lewis</dc:creator><dc:creator> Zachary T Martin</dc:creator><dc:creator> Jordan E Parker</dc:creator><dc:date> 2025-02-17</dc:date><dc:source>循环</dc:source><dc:title>Missing (Black) Women</dc:title><dc:identifier> pmid:39960982</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.124.072699</dc:identifier></item><item><title> Genes of the Fatty Acid Oxidation Pathway are Upregulated in Female as Compared to Male Cardiomyocytes</title><link/> https://pubmed.ncbi.nlm.nih.gov/39960981/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250219071916&amp;v=2.18.0.post9+e462414<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2025 Feb 18;151(7):511-514. doi: 10.1161/CIRCULATIONAHA.124.071973. Epub 2025 Feb 17.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39960981/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39960981</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071973>10.1161/CIRCULATIONAHA.124.071973</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39960981</guid><pubDate> Mon, 17 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Maya Talukdar</dc:creator><dc:creator> Lukáš Chmátal</dc:creator><dc:creator> Linyong Mao</dc:creator><dc:creator> Daniel Reichart</dc:creator><dc:creator> Danielle S Murashige</dc:creator><dc:creator> Helen Skaletsky</dc:creator><dc:creator> Daniel M DeLaughter</dc:creator><dc:creator> Zoltan Arany</dc:creator><dc:creator> Jonathan G Seidman</dc:creator><dc:creator> Christine E Seidman</dc:creator><dc:creator> David C Page</dc:creator><dc:date> 2025-02-17</dc:date><dc:source>循环</dc:source><dc:title>Genes of the Fatty Acid Oxidation Pathway are Upregulated in Female as Compared to Male Cardiomyocytes</dc:title><dc:identifier> pmid:39960981</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.124.071973</dc:identifier></item><item><title> Go Red for Women at 20 Years: Where Do We Go From Here?</title><link/> https://pubmed.ncbi.nlm.nih.gov/39960980/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250219071916&amp;v=2.18.0.post9+e462414<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> <b>Circulation</b> . 2025 Feb 18;151(7):e39-e40. doi: 10.1161/CIRCULATIONAHA.124.073637. Epub 2025 Feb 17.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39960980/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39960980</a> | DOI: <a href=https://doi.org/10.1161/CIRCULATIONAHA.124.073637>10.1161/CIRCULATIONAHA.124.073637</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39960980</guid><pubDate> Mon, 17 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Keith Churchwell</dc:creator><dc:creator> Stacey E Rosen</dc:creator><dc:date> 2025-02-17</dc:date><dc:source>循环</dc:source><dc:title>Go Red for Women at 20 Years: Where Do We Go From Here?</dc:title><dc:identifier> pmid:39960980</dc:identifier><dc:identifier> doi:10.1161/CIRCULATIONAHA.124.073637</dc:identifier></item><item><title> Clarification on methodology used in the study investigating COVID-19 vaccination and cardiovascular events</title><link/> https://pubmed.ncbi.nlm.nih.gov/39960846/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250219071916&amp;v=2.18.0.post9+e462414<description> No abstract </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"> Eur Heart J. 2025 Feb 17:ehaf063. doi: 10.1093/eurheartj/ehaf063. Online ahead of print.</p><p> <b>NO ABSTRACT</b></p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39960846/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250219071916&v=2.18.0.post9+e462414">39960846</a> | DOI: <a href=https://doi.org/10.1093/eurheartj/ehaf063>10.1093/eurheartj/ehaf063</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39960846</guid><pubDate> Mon, 17 Feb 2025 06:00:00 -0500</pubDate><dc:creator> Yiyi Xu</dc:creator><dc:creator> Fredrik Nyberg</dc:creator><dc:date> 2025-02-17</dc:date><dc:source> European heart journal</dc:source><dc:title> Clarification on methodology used in the study investigating COVID-19 vaccination and cardiovascular events</dc:title><dc:identifier> pmid:39960846</dc:identifier><dc:identifier> doi:10.1093/eurheartj/ehaf063</dc:identifier></item></channel></rss>